α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells
Proceedings of the National Academy of Sciences · 28.07.2026 · 123 (30)
DOI: 10.1073/pnas.2533427123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.07.2026. Verfasst von Mingyong Tan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: beta-Arrestin 1, Sphingosine-1-Phosphate Receptors, beta-Alanine, Colorectal Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
α-fluoro-β-alanine (FBAL), a catabolite of the chemotherapeutic agent 5-fluorouracil (5-FU), has attracted significant attention due to its cardiotoxicity and neurotoxicity. However, its association with 5-FU resistance, a major obstacle in cancer treatment, has rarely been reported. In this study, FBAL was identified as a β-arrestin1-biased ligand of sphingosine 1-phosphate receptor 2 (S1PR2), which upregulates dihydropyrimidine dehydrogenase (DPD) expression and drives 5-FU resistance in colorectal cancer. Mechanistically, following exposure to FBAL, S1PR2, a G protein–coupled receptor (GPCR), is phosphorylated by recruiting G protein–coupled receptor kinase 6 (GRK6). Phosphorylated S1PR2 coupled with β-arrestin1, but not G proteins, to activate the MEK/ERK/AP-1 pathway and promote DPYD transcription. Ser343 was identified as the key phosphorylation site of S1PR2 using IP-MS analysis. This residue within the C-terminal domain mediates receptor interaction with β-arrestin-1 to activate the β-arrestin-1-dependent ERK pathway, as was confirmed in HCT116 S1PR2KO-ΔC cells and HCT116 S1PR2KO-S343A cells. In vivo , mice bearing orthotopic xenografts of HCT116 S1PR2KO-S343A cells exhibited significantly enhanced higher sensitivity to 5-FU treatment compared to those HCT116 S1PR2KO-WT cells following FBAL. Taken together, this study showed that exposure to FBAL induces S1PR2 phosphorylation at Ser343 within the C-terminal mediated by GRK6, activating the β-arrestin1-dependent ERK pathway to upregulate DPD expression. This study not only delineates a phosphorylation-dependent signaling pathway in chemoresistance but also establishes S1PR2 as a promising therapeutic target for overcoming 5-FU resistance in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing 100069, China.
- Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
- Joint Laboratory for Research and Treatment of Spinal Cord Injury in Spinal Deformity, Capital Medical University, Beijing 100069, China.
- Department of Orthopedic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
ORCID-Profile: Xinan Zhang, Shuxiang Cui, Xianjun Qu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Tan, M., Shao, H., Zhang, X., Cheng, Y., Sun, Z., Yang, M., Mu, S., Liang, W., Han, B., Wu, X., Liu, X., Hai, Y., Cui, S., & Qu, X. (2026). α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells. Proceedings of the National Academy of Sciences, 123(30). https://doi.org/10.1073/pnas.2533427123
Vancouver
Tan M, Shao H, Zhang X, Cheng Y, Sun Z, Yang M, et al. α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells. Proceedings of the National Academy of Sciences. 2026;123(30). doi:10.1073/pnas.2533427123
BibTeX
@article{Tan2026,
author = {Tan, Mingyong and Shao, Hanbing and Zhang, Xinan and Cheng, Yuyao and Sun, Zhimeng and Yang, Ming and Mu, Siyuan and Liang, Weishi and Han, Bo and Wu, Xinfeng and Liu, Xiaohui and Hai, Yong and Cui, Shuxiang and Qu, Xianjun},
title = {α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {30},
doi = {10.1073/pnas.2533427123}
}
EUVIMED